| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.006 | 0.8 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |